Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Organogenesis Holdings (ORGO) Non-Current Receivables (2016 - 2020)

Organogenesis Holdings has reported Non-Current Receivables over the past 5 years, most recently at $302000.0 for Q2 2020.

  • Quarterly results put Non-Current Receivables at $302000.0 for Q2 2020, down 41.47% from a year ago — trailing twelve months through Jun 2020 was $302000.0 (down 41.47% YoY), and the annual figure for FY2019 was $556000.0, up 16.56%.
  • Non-Current Receivables for Q2 2020 was $302000.0 at Organogenesis Holdings, down from $576000.0 in the prior quarter.
  • Over the last five years, Non-Current Receivables for ORGO hit a ceiling of $576000.0 in Q1 2020 and a floor of $302000.0 in Q2 2020.
  • Median Non-Current Receivables over the past 5 years was $486500.0 (2018), compared with a mean of $476400.0.
  • Biggest five-year swings in Non-Current Receivables: grew 16.56% in 2019 and later plummeted 41.47% in 2020.
  • Organogenesis Holdings' Non-Current Receivables stood at $415000.0 in 2016, then decreased by 0.48% to $413000.0 in 2017, then rose by 15.5% to $477000.0 in 2018, then rose by 16.56% to $556000.0 in 2019, then crashed by 45.68% to $302000.0 in 2020.
  • The last three reported values for Non-Current Receivables were $302000.0 (Q2 2020), $576000.0 (Q1 2020), and $556000.0 (Q4 2019) per Business Quant data.